|
|
Suppliers for
Brivanib alaninate
|
Properties | CAS |
649735-63-7 | Formula |
C22H24FN5O4 |
|
|
5 Registered suppliers
Description : Brivanib alaninate is the alaninate ester of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression. Check for active clinical trials or closed clinical trials using this agent. Molecular Formula : C22H24FN5O4 Canonical SMILES : CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)OC(=O)C(C)N)C InChI : InChI=1S/C22H24FN5O4/c1-11-7-15-16(27-11)5-6-17(19(15)23)32-21-20-13(3)18(8-28(20)26-10-25-21)30-9-12(2)31-22(29)14(4)24/h5-8,10,12,14,27H,9,24H2,1-4H3/t12-,14+/m1/s1 InChIKey : LTEJRLHKIYCEOX-OCCSQVGLSA-N Synonyms : BMS-582664; BMS582664; BMS 582664
More details are to be found here
|
|
|
Privileged suppliers
Last update 2024-05-26
|